NVX vs. STEM, ULBI, GWH, ELVA, CBAT, DFLI, SES, IMMR, PRCH, and RDVT Should you be buying NOVONIX stock or one of its competitors? The main competitors of NOVONIX include Stem (STEM), Ultralife (ULBI), ESS Tech (GWH), Electrovaya (ELVA), CBAK Energy Technology (CBAT), Dragonfly Energy (DFLI), SES AI (SES), Immersion (IMMR), Porch Group (PRCH), and Red Violet (RDVT). These companies are all part of the "computer and technology" sector.
NOVONIX (NASDAQ:NVX ) and Stem (NYSE:STEM ) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation.
Stem received 28 more outperform votes than NOVONIX when rated by MarketBeat users.
NOVONIX has a net margin of 0.00% compared to Stem's net margin of -40.03%. NOVONIX's return on equity of 0.00% beat Stem's return on equity.
NOVONIX has a beta of 3.16, indicating that its share price is 216% more volatile than the S&P 500. Comparatively, Stem has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.
In the previous week, NOVONIX had 1 more articles in the media than Stem. MarketBeat recorded 3 mentions for NOVONIX and 2 mentions for Stem. Stem's average media sentiment score of 1.01 beat NOVONIX's score of 0.39 indicating that Stem is being referred to more favorably in the news media.
0.1% of NOVONIX shares are owned by institutional investors. Comparatively, 61.6% of Stem shares are owned by institutional investors. 23.7% of NOVONIX shares are owned by insiders. Comparatively, 10.2% of Stem shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
NOVONIX has higher earnings, but lower revenue than Stem.
Stem has a consensus price target of $4.77, indicating a potential upside of 274.36%. Given Stem's higher possible upside, analysts clearly believe Stem is more favorable than NOVONIX.
Summary NOVONIX beats Stem on 8 of the 14 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding NVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
